An additional site mutation in MITA/STING gain-of-function mutants abolishes the autoimmune SAVI phenotypes and directs a therapeutic strategy
Cited by 0
Related Papers
CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer
|Nature Communications|2020|206
USP13 negatively regulates antiviral responses by deubiquitinating STING
|Nature Communications|2017|194
RNF115 plays dual roles in innate antiviral responses by catalyzing distinct ubiquitination of MAVS and MITA
|Nature Communications|2020|83